on the rise

With all the renewed interest in biotechs of late ie vcr,psd,mpb,ept to name a few it's worth having another look at the potential on offer with NAL. Eyecare is receiving positive feedback from clinical tests,sales of the lad devices is improving and the prospects for immunolgy are mind blowing.
The sell down was acheived on very small volume so the smart investors were happy to hold for the long term.I managed to top up at .34 cents (sorry Thymus)and am happy to sit and wait for positve news which will surely come if not re immunology definately re epilasik sales.
Of all the bios I think NAL will be the standout performer.AT .48 cents it's no brainer!!!